Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria

ClinicalTrials.gov ID: NCT02392624

Public ClinicalTrials.gov record NCT02392624. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

XTEND-CIU (Xolair Treatment Efficacy of Longer Duration in Chronic Idiopathic Urticaria): A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab Through 48 Weeks in Patients With Chronic Idiopathic Urticaria

Study identification

NCT ID
NCT02392624
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Genentech, Inc.
Industry
Enrollment
206 participants

Conditions and interventions

Conditions

Interventions

  • Omalizumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 17, 2015
Primary completion
Mar 8, 2017
Completion
Mar 8, 2017
Last update posted
Mar 28, 2018

2015 – 2017

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Allergy and Asthma Relief Experts Granada Hills California 91344
Allergy & Asthma Care Center of Southern California Long Beach California 90808
Dermatology Research Associate Los Angeles California 90045
Southern California Research Center Mission Viejo California 92691
Choc Psf, Amc Orange California 92868
Allergy & Asthma Consultants Redwood City California 94063
Allergy and Asthma Clinical Research, Inc. Walnut Creek California 94598
IMMUNOe Research Centers Centennial Colorado 80112
Colorado Allergy & Asthma Centers, Pc Denver Colorado 80230
Florida Center for Allergy and Asthma Research Aventura Florida 33180
Florida Ctr-Allergy & Asthma Miami Florida 33173
Sarasota Clinical Research Sarasota Florida 34239
University of South Florida Tampa Florida 33613
Clinical Research Center of Southern Illinois LLC Shiloh Illinois 62269
Deaconess Clinic Evansville Indiana 47713
Dawes Fretzin Clinical Res LLC Indianapolis Indiana 46256
Abraham Research PLLC Fort Mitchell Kentucky 41017
Dermatology Specialists Research, LLC Louisville Kentucky 40241
Allergy & Asthma Specialists, PSC Owensboro Kentucky 42301
Asthma, Allergy & Sinus Center Baltimore Maryland 21236
Institute for Asthma & Allergy Chevy Chase Maryland 20815
Respiratory Medicine Research; Institue of Michigan P.L.C. Ypsilanti Michigan 48197
James Q. Del Rosso, DO, LLC Las Vegas Nevada 89117
Ocean Allergy & Resp Res Ctr Brick New Jersey 08724
Winthrop University Hospital Mineola New York 11501
Aair Research Center Rochester New York 14618
University of Rochester Medical Center; University Dermatology Associates Rochester New York 14642
Montefiore Medical Group;Department of Medicine The Bronx New York 10461
Allergy Partners of Western NC Asheville North Carolina 28801
Allergy & Respiratory Center Canton Ohio 44718
Bernstein Clinical Research Center Llc Cincinnati Ohio 45231
Toledo Inst of Clin Research Toledo Ohio 43617
Vital Prospects Clin Res Pc Tulsa Oklahoma 74136
Asthma, Nasal Disease, and Allergy Research Center of New England East Providence Rhode Island 02914
National Allergy and Asthma Research Charleston South Carolina 29407
Live Oak Allergy & Asthma Clinic Live Oak Texas 78233
Allergy & Asthma Research Center San Antonio Texas 78229
Timber Lane Allergy-Asth Res South Burlington Vermont 05403
O & O Alpan, LLC Fairfax Virginia 22030
Premier Clinical Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02392624, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02392624 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →